Select a community
PSP including CBD
Find out more about the PatientsLikeMe
PSP Community
Home > Community Treatment Reports > Carbidopa-Levodopa Treatment Report
What is Carbidopa-Levodopa?

Levodopa is a dopamine precursor used to treat the movement disorder symptoms of Parkinson's disease. Carbidopa is often included with levodopa-containing drugs in order to boost its efficacy by slowing down the metabolism of dopamine.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken
# of patients Efficacy
Major
Moderate
Slight
None
Can’t tell 		# of patients evaluated by
Other 1 0
Progressive Supranuclear Palsy PSP 1 0

See all 3 patients currently taking Carbidopa-Levodopa

Mouse over the table for more information

Dosages

  3 x 10 mg-100 mg daily 3 x 25 mg-100 mg daily 6 x 25 mg-100 mg daily
  1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Carbidopa-Levodopa (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 100% Did not seem to work: 100%
Personal research
1 100% Personal research: 100%

See all 1 patient who’ve stopped taking Carbidopa-Levodopa

Duration See details about how long patients take this treatment ▼

Currently Taking Carbidopa-Levodopa

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Carbidopa-Levodopa

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 21, 2010.